Safety Concerns At Compounding Pharmacies

Safety Concerns At Compounding Pharmacies

New reports tie safety failures at specialty pharmacies to deaths and illnesses over the past decade. A panel joins Diane to discuss widespread problems at compounding pharmacies.

A deadly meningitis outbreak last year drew attention to a relatively new segment of the drug industry: large-scale compounding pharmacies. The Food and Drug Administration is calling for new, stronger and clearer legislation to effectively oversee firms that mix custom drugs for specific patients. In the past two decades, compounding pharmacies have grown into a multimillion dollar business, making some of the highest risk drugs available. But they are not required to follow the safety rules that apply to commercial drug makers. State pharmacy boards have an uneven record of policing them. A panel joins Diane to discuss efforts to improve the safety and oversight of compounded drugs.


Lena Sun

reporter, The Washington Post.

Kasey Thompson

vice president of policy, planning and communications for the American Society of Health-System Pharmacists.

David Miller

executive vice president, International Academy of Compounding Pharmacists.

Carmen Catizone

executive director, National Association of Boards of Pharmacy.

Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.

Our address has changed!

The Diane Rehm Show is produced by member-supported WAMU 88.5 in Washington DC.